✓ Medically reviewed by  ·  Last reviewed: May 2026

Morgan Ellis

Pharmacy Researcher · 8 years experience

Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.

How to Read a Peptide Certificate of Analysis: HPLC Purity, Mass Spec Confirmation, and Sequence Verification

The Certificate of Analysis (COA) is the document that proves a peptide batch is what the label says it is. For research-grade laboratory work, the COA is non-negotiable — without it, you can’t verify identity, purity, or quantity. This guide walks through the four sections of a typical peptide COA and explains how to interpret each one. Every batch shipped from MedsBase comes with batch-specific COA available on request.

The four sections that matter

A typical peptide COA includes:

1. Identity verification — mass spectrometry (MS) showing the observed molecular weight matches the theoretical molecular weight
2. Purity assessment — high-performance liquid chromatography (HPLC) chromatogram showing the peptide as a clean single peak with purity percentage
3. Sequence verification — confirmation that the actual amino-acid sequence matches the labelled sequence (typically via MS/MS fragmentation or sequencing)
4. Quantity — per-vial mass of peptide, supporting accurate reconstitution math

Some COAs also include appearance (visual description of the lyophilized cake), solubility testing, amino-acid analysis (a complementary identity check), and bioactivity assays for specific molecules. These are bonuses; the four above are the core.

1. Identity verification: mass spectrometry

Mass spectrometry measures the molecular weight of the peptide. The COA shows the observed mass and compares it to the theoretical mass calculated from the amino-acid sequence. For research-grade peptides:

• Acceptable match: observed mass within 1-2 Da of theoretical mass for synthetic peptides under ~3 kDa; within 5 Da for larger peptides; within 0.05% for recombinant proteins (mass spectrometers have different precision at different mass ranges)
• Common notation: the COA may show “observed [M+H]+ = 1420.5, theoretical [M+H]+ = 1420.6” for BPC-157 (the +H indicates the protonated form measured by electrospray ionisation MS)
• Red flags: observed mass differing by more than the tolerance suggests either wrong peptide, partial-sequence peptide (truncation), or modification (e.g., oxidation adding ~16 Da, or acetylation adding ~42 Da). Reject batches where the MS doesn’t confirm identity.

2. Purity assessment: HPLC chromatogram

HPLC is the gold-standard purity measurement for peptides. The chromatogram shows a series of peaks where each peak corresponds to a distinct compound eluting from the chromatography column. For a clean peptide preparation:

• Ideal chromatogram: one tall sharp peak at the expected retention time, with no other peaks (or only tiny solvent / system peaks at the start)
• Purity percentage: calculated as the area of the main peak divided by the total area of all peaks × 100. Research-grade peptides are typically ≥98% pure; high-grade research material is ≥99%
• Red flags: multiple substantial peaks (indicates impurities); a “shoulder” on the main peak (suggests a closely-eluting impurity, often a sequence variant or oxidation product); a substantially smaller main peak than expected (low overall yield)
• What to look for visually: Sharp narrow peak shape (good); broad or asymmetric peak (less clean material); flat or noisy baseline (good); raised or noisy baseline (column or detector issues)

3. Sequence verification

For research-grade peptides, sequence verification is typically done via tandem mass spectrometry (MS/MS) or Edman degradation. The COA may show:

• MS/MS fragmentation pattern — the peptide is fragmented at the peptide bonds and the fragment masses are matched to the expected sequence. A correct sequence produces a characteristic fragment-mass pattern that confirms the amino-acid order.
• Edman degradation — sequential N-terminal residue identification by chemical cleavage. Older technique, more time-consuming, but produces direct sequence readout.
• Amino-acid analysis (AAA) — the peptide is hydrolyzed to its constituent amino acids and the molar ratios measured. Confirms composition but not order; complementary to MS/MS.

For most synthetic peptides under ~50 residues, MS/MS sequence confirmation is the standard. Larger recombinant proteins (follistatin 344, GDF-8) typically use peptide-mapping techniques where the protein is digested with a specific protease, the resulting peptide fragments are run through MS, and the fragment masses are matched to the expected sequence.

4. Quantity: per-vial mass

The COA states the peptide mass per vial. For research-protocol use, this is the number you plug into the reconstitution math. Common conventions:

• Net peptide mass — the actual peptide content. This is what you use in concentration calculations.
• Gross mass — the total lyophilized cake mass, which includes counterion content (typically acetate or TFA), residual water, and bulking agents (rarely used in research-grade material). For most research applications, the net peptide mass is what matters.
• Counterion notation: a peptide may be reported as “X mg as net peptide; counterion: acetate” or “X mg as TFA salt.” The counterion accounts for ~5-15% of the gross mass for typical synthetic peptides.

Verify the net peptide mass matches the label claim. A 5 mg vial of BPC-157 should have ~5 mg of net BPC-157 peptide content; substantial deviation (more than ~10%) is a red flag.

What a good COA looks like vs a poor COA

Requesting a COA

For any peptide ordered from MedsBase, the batch-specific COA is available on request after order placement. Contact support with the batch identifier printed on the vial label; the COA will be emailed back within one business day. The COA should match the specific batch you received (not a generic batch-independent document).

Common COA misconceptions

• “A COA means the peptide is FDA-approved.” No. A COA is a quality-control document for research-grade material; it has nothing to do with regulatory approval for human therapeutic use. The peptides on the catalogue are sold for laboratory research use only.
• “99% purity means the rest is just water.” No. The remaining 1-2% is typically other peptide species — truncation products, sequence variants, oxidation products, deletion sequences. The “1% other” is usually peptide-related impurities, not bulk water or counterion.
• “Older COAs are unreliable.” A COA is a snapshot of the peptide at the time of analysis. Provided storage has been correct, the peptide is what the COA says it is. The COA doesn’t degrade over time even though peptide stored badly will.
• “Generic COAs are equivalent to batch-specific COAs.” Not for research-grade purposes. The batch-specific COA proves the analysis was performed on the actual lot you received. Generic / non-batch-specific COAs are essentially manufacturer specifications, not analytical proof of your specific material.

FAQ

How do I request a COA for my order?

Contact MedsBase support after order placement with the batch identifier printed on your vial label. The batch-specific COA will be emailed back within one business day.

What HPLC purity is acceptable for research use?

≥99% is the high-grade research-material standard. ≥98% is acceptable for most research applications. Below 98% suggests substantial impurities and is worth investigating — reject batches where the HPLC shows clear multi-peak patterns rather than a clean single peak.

What does the mass spectrometry section tell me?

That the molecule is what the label says it is. Observed mass within 1-2 Da of theoretical mass confirms the molecular identity. Larger discrepancies suggest wrong peptide, truncation product, or modification — reject the batch.

Why does the COA include a chromatogram image?

So you can visually verify the purity assessment. A clean single sharp peak at the expected retention time is the visual confirmation of high purity. Multiple peaks, shoulder peaks, or broad peak shapes indicate quality issues that the numerical purity percentage might not fully capture.

What does “counterion” mean on a COA?

The salt form of the peptide. Most synthetic peptides are isolated as acetate or trifluoroacetate (TFA) salts — the counterion accounts for ~5-15% of the gross mass. The “net peptide” mass excludes counterion; this is the number to use for concentration calculations.

What if the COA shows lower purity than expected?

Contact support before reconstituting. For research-protocol use, the purity affects the experimental design (impurities are confounders); a batch with substantially lower purity than expected should be replaced rather than used.

Bottom line

A peptide Certificate of Analysis proves identity (mass spectrometry matches theoretical molecular weight), purity (HPLC shows ≥99% clean single peak), sequence (MS/MS or AAA confirms amino-acid order), and quantity (per-vial mass for reconstitution math). Every batch should have a batch-specific COA available on request. Researchers who can read a COA fluently can verify their material before committing to a research protocol — one of the highest-leverage trust signals in the laboratory research supply chain.

Written by

Sophie Chen

Pharmaceutical Content Researcher · 8 years experience

Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.